ESC Premium Access

Late Breaking Trials in ACS

Event: ESC Congress 2021 - The Digital Experience
Topic: Acute Coronary Syndromes
Session type: Late-Breaking Science
Date: 27 August 2021
Time: 10:30 - 11:15

Congress Session

Become an ESC member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

QUORUM : Quantum Genomics Firibastat (QGC001) or Ramipril after Acute Myocardial Infarction for Prevention of Left Ventricular Dysfunction

Speaker: Professor G. Montalescot (Paris, FR)
Thumbnail

HUYGENS: Evolocumab and changes in plaque composition on OCT

Speaker: Professor S. Nicholls (Melbourne, AU)
Thumbnail

ACCOST-HH: Adrecizumab in cardiogenic shock

Speaker: Doctor M. Karakas (Hamburg, DE)
Thumbnail

Low-dose rivaroxaban during the acute phase of ACS - H-REPLACE Trial)

Speaker: Professor S. Zhou (Changsha, CN)
Thumbnail

4 speakers from this session

Professor Gilles Montalescot

Sorbonne University, Paris (France)
24 presentations
1 follower

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
1 follower

Doctor Mahir Karakas

The University Medical Center Hamburg-Eppendorf, Hamburg (Germany)
3 presentations
0 follower

Professor Shenghua Zhou

The Second Xiangya Hospital of Central South University, Changsha (China)
1 presentation
0 follower

This platform is supported by

logo Novo Nordisk